Circulating levels of high molecular weight (HMW) adiponectin and total adiponectin in relation to fat distribution, oxidative stress and inflammation in Asian Indians. 2012

K Indulekha, and J Surendar, and R M Anjana, and K Gokulakrishnan, and M Balasubramanyam, and V Aravindhan, and V Mohan
Madras Diabetes Research Foundation and Dr.\ Mohan's Diabetes Specialities Centre, WHO Collaborating Centre for Non-Communicable Diseases Prevention and Control, International Diabetes Federation Centre for Education, Gopalapuram, Chennai, India.

OBJECTIVE To look at the association of total and high molecular weight (HMW) adiponectin with markers of fat distribution, oxidative stress and inflammation in Asian Indians. METHODS A total of 120 subjects were chosen randomly from Chennai Urban Rural Epidemiological Study. Fasting HMW adiponectin levels, TNF-alpha and oxidized LDL were measured using ELISA. High sensitivity C reactive protein (hsCRP) was measured by a high sensitive nephelometric assay. Lipid peroxidation was measured by Tbars assay and protein carbonyl content was assessed by DNPH assay. Visceral and subcutaneous fat areas were assessed by computed tomography (CT) scan. RESULTS When stratified based on the tertiles of visceral fat, the levels of total (p=0.03) and HMW adiponectin (p=0.007) were highest in the first tertile followed by tertiles 2 and 3 whereas in tertiles of subcutaneous fat, there was no such trend. With increasing tertiles of Tbars, the levels of total (p=0.03) and HMW adiponectin decreased (p=0.002). The levels of HMW (p< 0.001) but not total adiponectin was also found to decrease with increasing tertiles of Protein carbonyl content. The levels of Total (p=0.02) and HMW adiponectin (p=0.004) were highest in the first tertile of oxidized LDL followed by tertile 2 and tertile 3. With increasing tertiles of TNF-alpha total (p=0.01) and HMW adiponectin (p=0.004) was found to decrease. With increasing tertiles of hs-CRP, Total (p=0.005) and HMW adiponectin (p=0.007)was found to decrease. CONCLUSIONS Oxidative stress markers, visceral but not subcutaneous fat and inflammation are associated with total and HMW adiponectin levles in Asian Indians.

UI MeSH Term Description Entries
D007194 India A country in southern Asia, bordering the Arabian Sea and the Bay of Bengal, between Burma and Pakistan. The capitol is New Delhi. Republic of India
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D008077 Lipoproteins, LDL A class of lipoproteins of small size (18-25 nm) and light (1.019-1.063 g/ml) particles with a core composed mainly of CHOLESTEROL ESTERS and smaller amounts of TRIGLYCERIDES. The surface monolayer consists mostly of PHOSPHOLIPIDS, a single copy of APOLIPOPROTEIN B-100, and free cholesterol molecules. The main LDL function is to transport cholesterol and cholesterol esters to extrahepatic tissues. Low-Density Lipoprotein,Low-Density Lipoproteins,beta-Lipoprotein,beta-Lipoproteins,LDL(1),LDL(2),LDL-1,LDL-2,LDL1,LDL2,Low-Density Lipoprotein 1,Low-Density Lipoprotein 2,LDL Lipoproteins,Lipoprotein, Low-Density,Lipoproteins, Low-Density,Low Density Lipoprotein,Low Density Lipoprotein 1,Low Density Lipoprotein 2,Low Density Lipoproteins,beta Lipoprotein,beta Lipoproteins
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D002097 C-Reactive Protein A plasma protein that circulates in increased amounts during inflammation and after tissue damage. C-Reactive Protein measured by more sensitive methods often for coronary heart disease risk assessment is referred to as High Sensitivity C-Reactive Protein (hs-CRP). High Sensitivity C-Reactive Protein,hs-CRP,hsCRP,C Reactive Protein,High Sensitivity C Reactive Protein
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000273 Adipose Tissue Specialized connective tissue composed of fat cells (ADIPOCYTES). It is the site of stored FATS, usually in the form of TRIGLYCERIDES. In mammals, there are two types of adipose tissue, the WHITE FAT and the BROWN FAT. Their relative distributions vary in different species with most adipose tissue being white. Fatty Tissue,Body Fat,Fat Pad,Fat Pads,Pad, Fat,Pads, Fat,Tissue, Adipose,Tissue, Fatty

Related Publications

K Indulekha, and J Surendar, and R M Anjana, and K Gokulakrishnan, and M Balasubramanyam, and V Aravindhan, and V Mohan
December 2013, Journal of endocrinological investigation,
K Indulekha, and J Surendar, and R M Anjana, and K Gokulakrishnan, and M Balasubramanyam, and V Aravindhan, and V Mohan
February 2014, Obesity (Silver Spring, Md.),
K Indulekha, and J Surendar, and R M Anjana, and K Gokulakrishnan, and M Balasubramanyam, and V Aravindhan, and V Mohan
July 2013, Obesity (Silver Spring, Md.),
K Indulekha, and J Surendar, and R M Anjana, and K Gokulakrishnan, and M Balasubramanyam, and V Aravindhan, and V Mohan
January 2015, PloS one,
K Indulekha, and J Surendar, and R M Anjana, and K Gokulakrishnan, and M Balasubramanyam, and V Aravindhan, and V Mohan
August 2012, International journal of obesity (2005),
K Indulekha, and J Surendar, and R M Anjana, and K Gokulakrishnan, and M Balasubramanyam, and V Aravindhan, and V Mohan
January 2013, Central Asian journal of global health,
K Indulekha, and J Surendar, and R M Anjana, and K Gokulakrishnan, and M Balasubramanyam, and V Aravindhan, and V Mohan
May 2009, Metabolism: clinical and experimental,
K Indulekha, and J Surendar, and R M Anjana, and K Gokulakrishnan, and M Balasubramanyam, and V Aravindhan, and V Mohan
January 2014, BMC clinical pathology,
K Indulekha, and J Surendar, and R M Anjana, and K Gokulakrishnan, and M Balasubramanyam, and V Aravindhan, and V Mohan
April 2008, Journal of immunological methods,
K Indulekha, and J Surendar, and R M Anjana, and K Gokulakrishnan, and M Balasubramanyam, and V Aravindhan, and V Mohan
January 2013, ISRN endocrinology,
Copied contents to your clipboard!